Our results indicate that alterations of SGCG, PROS1 and ITGB1 genes appeared prevalently in grade III astrocytomas and resulted in shorter survival of patients, implying more aggressive nature of tumors with this genetic signature. The gene discussed is SGCG; the disease is astrocytoma (excluding glioblastoma).